
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selecting Appropriate Management Strategies for Chronic Hepatitis B: Who to Treat
Brian J. McMahon
The American Journal of Gastroenterology (2006) Vol. 101, Iss. S1, pp. S7-S12
Closed Access | Times Cited: 30
Brian J. McMahon
The American Journal of Gastroenterology (2006) Vol. 101, Iss. S1, pp. S7-S12
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Long‐term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e‐antigen seroclearance
James Fung, Ka Shing Cheung, Danny Ka‐Ho Wong, et al.
Hepatology (2018) Vol. 68, Iss. 2, pp. 462-472
Closed Access | Times Cited: 58
James Fung, Ka Shing Cheung, Danny Ka‐Ho Wong, et al.
Hepatology (2018) Vol. 68, Iss. 2, pp. 462-472
Closed Access | Times Cited: 58
HIV/AIDS: Antiretroviral Therapy for Hepatitis B Virus–HIV–Coinfected Patients: Promises and Pitfalls
Vivian Levy, Robert M. Grant
Clinical Infectious Diseases (2006) Vol. 43, Iss. 7, pp. 904-910
Open Access | Times Cited: 80
Vivian Levy, Robert M. Grant
Clinical Infectious Diseases (2006) Vol. 43, Iss. 7, pp. 904-910
Open Access | Times Cited: 80
Genotype B and Younger Patient Age Associated with Better Response to Low-Dose Therapy: A Trial with Pegylated/Nonpegylated Interferon- -2b for Hepatitis B e Antigen--Positive Patients with Chronic Hepatitis B in China
Hong Zhao, Fuat Kurbanov, M.-B. Wan, et al.
Clinical Infectious Diseases (2007) Vol. 44, Iss. 4, pp. 541-548
Open Access | Times Cited: 75
Hong Zhao, Fuat Kurbanov, M.-B. Wan, et al.
Clinical Infectious Diseases (2007) Vol. 44, Iss. 4, pp. 541-548
Open Access | Times Cited: 75
Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)
Lionel Piroth, D. Sène, Stanislas Pol, et al.
AIDS (2007) Vol. 21, Iss. 10, pp. 1323-1331
Open Access | Times Cited: 62
Lionel Piroth, D. Sène, Stanislas Pol, et al.
AIDS (2007) Vol. 21, Iss. 10, pp. 1323-1331
Open Access | Times Cited: 62
Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine
Silvia Gaia, V. Barbon, Antonina Smedile, et al.
Journal of Hepatology (2008) Vol. 48, Iss. 4, pp. 540-547
Closed Access | Times Cited: 46
Silvia Gaia, V. Barbon, Antonina Smedile, et al.
Journal of Hepatology (2008) Vol. 48, Iss. 4, pp. 540-547
Closed Access | Times Cited: 46
Current treatment of hepatitis B
Geoffrey Dusheiko, N. Antonakopoulos
Gut (2007) Vol. 57, Iss. 1, pp. 105-124
Closed Access | Times Cited: 34
Geoffrey Dusheiko, N. Antonakopoulos
Gut (2007) Vol. 57, Iss. 1, pp. 105-124
Closed Access | Times Cited: 34
Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth
Luo Xiangji, Xinwei Feng, Cheng Qingbao, et al.
Journal of Viral Hepatitis (2010) Vol. 18, Iss. 9, pp. 653-660
Closed Access | Times Cited: 25
Luo Xiangji, Xinwei Feng, Cheng Qingbao, et al.
Journal of Viral Hepatitis (2010) Vol. 18, Iss. 9, pp. 653-660
Closed Access | Times Cited: 25
Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies
George Lau, Patrick Marcellin, Marion G. Peters
Hepatology International (2007) Vol. 1, Iss. 2, pp. 316-325
Open Access | Times Cited: 22
George Lau, Patrick Marcellin, Marion G. Peters
Hepatology International (2007) Vol. 1, Iss. 2, pp. 316-325
Open Access | Times Cited: 22
HBeAg‐positive chronic hepatitis B: why do I treat my patients with pegylated interferon
George Lau
Liver International (2009) Vol. 29, Iss. s1, pp. 125-129
Open Access | Times Cited: 18
George Lau
Liver International (2009) Vol. 29, Iss. s1, pp. 125-129
Open Access | Times Cited: 18
Chronic HBV Infection outside Treatment Guidelines: Is Treatment Needed?
Alison A. Evans, William T. London, Robert G. Gish, et al.
Antiviral Therapy (2012) Vol. 18, Iss. 2, pp. 229-235
Closed Access | Times Cited: 16
Alison A. Evans, William T. London, Robert G. Gish, et al.
Antiviral Therapy (2012) Vol. 18, Iss. 2, pp. 229-235
Closed Access | Times Cited: 16
Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran
Mohammad Amin Behzadi, Mazyar Ziyaeyan, Sadaf Asaei
Jundishapur Journal of Microbiology (2014) Vol. 7, Iss. 5
Open Access | Times Cited: 11
Mohammad Amin Behzadi, Mazyar Ziyaeyan, Sadaf Asaei
Jundishapur Journal of Microbiology (2014) Vol. 7, Iss. 5
Open Access | Times Cited: 11
Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital.
David Widjaja, Suresh Yarlagadda, Bheema S. Singu, et al.
Journal of the National Medical Association (2007) Vol. 99, Iss. 4, pp. 384-8
Closed Access | Times Cited: 14
David Widjaja, Suresh Yarlagadda, Bheema S. Singu, et al.
Journal of the National Medical Association (2007) Vol. 99, Iss. 4, pp. 384-8
Closed Access | Times Cited: 14
Maintaining remission in lamivudine‐resistant patients with a virological response to adefovir add‐on lamivudine after stopping lamivudine therapy
Mi Na Kim, Chun Kyon Lee, Sang Hoon Ahn, et al.
Liver International (2013) Vol. 34, Iss. 10, pp. 1543-1549
Closed Access | Times Cited: 10
Mi Na Kim, Chun Kyon Lee, Sang Hoon Ahn, et al.
Liver International (2013) Vol. 34, Iss. 10, pp. 1543-1549
Closed Access | Times Cited: 10
Treatment of HBeAg‐positive patients with nucleos/tide analogues
Carla S. Coffin, Samuel S. Lee
Liver International (2009) Vol. 29, Iss. s1, pp. 116-124
Open Access | Times Cited: 8
Carla S. Coffin, Samuel S. Lee
Liver International (2009) Vol. 29, Iss. s1, pp. 116-124
Open Access | Times Cited: 8
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
EunYoung Ze, Eun Kyung Baek, Joongku Lee, et al.
Clinical and Molecular Hepatology (2014) Vol. 20, Iss. 3, pp. 267-267
Open Access | Times Cited: 5
EunYoung Ze, Eun Kyung Baek, Joongku Lee, et al.
Clinical and Molecular Hepatology (2014) Vol. 20, Iss. 3, pp. 267-267
Open Access | Times Cited: 5
Current management and recommendations on hepatitis B therapy in HIV-coinfected patients
Lionel Piroth, Sophie Mahy, Stanislas Pol, et al.
Hepatology International (2011) Vol. 7, Iss. 2, pp. 437-442
Closed Access | Times Cited: 4
Lionel Piroth, Sophie Mahy, Stanislas Pol, et al.
Hepatology International (2011) Vol. 7, Iss. 2, pp. 437-442
Closed Access | Times Cited: 4
Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients
Min Lian, Xu Zhou, Lai Wei, et al.
Virology Journal (2007) Vol. 4, Iss. 1
Open Access | Times Cited: 5
Min Lian, Xu Zhou, Lai Wei, et al.
Virology Journal (2007) Vol. 4, Iss. 1
Open Access | Times Cited: 5
Defining Optimal Therapeutic Outcomes in Chronic Hepatitis
Mauricio Lisker‐Melman, Gregory S. Sayuk
Archives of Medical Research (2007) Vol. 38, Iss. 6, pp. 652-660
Closed Access | Times Cited: 4
Mauricio Lisker‐Melman, Gregory S. Sayuk
Archives of Medical Research (2007) Vol. 38, Iss. 6, pp. 652-660
Closed Access | Times Cited: 4
Évolution fatale après réactivation d’une hépatite chronique virale B occulte dans les suites d’une chimiothérapie pour lymphome chez un malade porteur de l’anticorps anti-HBc isolé
Anne Thirot‐Bidault, Jaata Ben Mansour, Olivier Lambotte, et al.
Gastroentérologie Clinique et Biologique (2007) Vol. 31, Iss. 11, pp. 1028-1031
Closed Access | Times Cited: 2
Anne Thirot‐Bidault, Jaata Ben Mansour, Olivier Lambotte, et al.
Gastroentérologie Clinique et Biologique (2007) Vol. 31, Iss. 11, pp. 1028-1031
Closed Access | Times Cited: 2
Update on Chronic Hepatitis B
Vinod K. Rustgi, Damaris Carriero, Michelle Bachtold, et al.
The Journal for Nurse Practitioners (2010) Vol. 6, Iss. 8, pp. 631-639
Closed Access | Times Cited: 1
Vinod K. Rustgi, Damaris Carriero, Michelle Bachtold, et al.
The Journal for Nurse Practitioners (2010) Vol. 6, Iss. 8, pp. 631-639
Closed Access | Times Cited: 1
Reviews on the Epidemiology, Quality of Life, and Management of Chronic Hepatitis B (CHB)
Elegance T.P., Cindy L.K.
InTech eBooks (2012)
Open Access
Elegance T.P., Cindy L.K.
InTech eBooks (2012)
Open Access
Pharmacotherapy of chronic viral hepatitis and hepatocellular carcinoma
Mark A. Feitelson, Marcia M. Clayton, Helena Reis, et al.
Expert Opinion on Pharmacotherapy (2008) Vol. 9, Iss. 13, pp. 2233-2245
Closed Access
Mark A. Feitelson, Marcia M. Clayton, Helena Reis, et al.
Expert Opinion on Pharmacotherapy (2008) Vol. 9, Iss. 13, pp. 2233-2245
Closed Access
Reply to McGovern
Vincent Lévy, Robert M. Grant
Clinical Infectious Diseases (2007) Vol. 44, Iss. 7, pp. 1013-1013
Open Access
Vincent Lévy, Robert M. Grant
Clinical Infectious Diseases (2007) Vol. 44, Iss. 7, pp. 1013-1013
Open Access